Khiron (KHRNF) is a cannabis company specializing in THC and CBD manufacturing and distribution in Latin America and Europe. With 15 health centers across the globe, they position themselves as a wellness company. But Is KHRNF a Strong Buy and Hold?
Khiron Life Sciences Corp is a THC and CBD company with small agricultural footprints. They distribute and sell products in Latin America and Europe with sales locations rolling out in Mexico this year. If they can take advantage of these emerging markets, it could be very big for them. They are much less competitive than the USA or Canada is for shelf space.
Khiron mostly has oils and flower products for sale currently but they are looking to expand that asap. Their largest market by far is Colombia, which is all their cultivation and manufacturing is located. Their sales are increasingly due to the cannabis flower though.
Bottom Line: Is KHRNF a Strong Buy and Hold?
The revenues have been increasing QoQ but they remain small ($3.5 million in Q3 2021). Recent quarterly financials show they are not profitable yet, with net losses around $3.34 million and EBITDA at negative $3.78 million. Their recent fundraising through share sales, has their cash and cash equivalents at $15.4 million which is enough for the next year or so plus a small acquisition if they so desire.
With flower sales driving their growth, it is a good sign that the flower margins are high, at nearly 85%, given the cheap cost to produce in Colombia. Increasing their footprint in Mexico, could be huge, as Mexico is the clear leader of the LatAm marketplace in terms of cultural influence and financial position. They are still too small and risky for us, but could be an acquisition target of any large company looking to expand their sales teams internationally. This is maybe a few years out though.
For all these reasons we rate KHRF as a Weak buy and hold stock.
Is KHRNF a Strong Buy and Hold?
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
